ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metabolomic analysis and pharmacological validation of the cerebral protective effect of 3,4-dihydroxybenzaldehyde on cerebral ischemia-reperfusion injury

Luo, Yuan; Chen, Pu; Yang, Liping; Duan, Xiaohua*云南大学
Molecular Medicine Reports2023-1DOI: 10.3892/mmr.2022.12896
1被引6阅读
引用收藏
分享

摘要

3,4-Dihydroxybenzaldehyde (DBD), one of the active components of Gastrodia elata, has a cerebral protective effect and can effectively combat cerebral ischemia/reperfusion (I/R) injury in rats. However, the metabolite profiles and underlying mechanisms associated with DBD remain unclear. To explore the level of energy metabolism and pharmacological targets in brain tissue following DBD treatment of stroke. The right middle cerebral artery of the rats was occluded for 2 h and reperfused for 24 h to simulate brain I/R injury. Pharmacological results showed that DBD reduced cerebral infarct volume, improved neurological function and increased adenosine triphosphate (ATP) content. Mitochondria are the primary sites for ATP generation and cellular energy supply and decreasing mitochondrial dysfunction can alleviate the energy expenditure of ischemic stroke. Through further experiments, it was found that mitochondrial damage was recovered following DBD treatment, which was manifested by the improvement of mitochondrial morphology under an electron microscope and the reduction of oxidative stress damage. The metabolomics of middle cerebral artery occlusion/reperfusion (MCAO/R) rat brain tissue was studied by the liquid chromatography-tandem mass spectrometry metabolomics method. Significantly different metabolites were screened and the pathways involved included amino sugar and nucleotide sugar metabolism and pentose phosphate pathway. Finally, the present study performed targeted metabolic profiling and validated potential therapeutic targets. Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) levels were decreased in the MCAO/R group but significantly increased in the DBD group. TdT-mediated dUTP nick end labeling (TUNEL) staining, hematoxylin and eosin staining and western blotting showed that brain cell apoptosis was inhibited and neuronal morphology improved. Among them, the regulatory enzyme O-GlcNAc transferase (OGT) of UDP-GlcNAc appeared to be significantly increased and neuronal apoptosis was inhibited following DBD treatment, which was verified by western blotting. Therefore, by analyzing mitochondrial dysfunction following I/R and the characterization of potential markers in mitochondrial energy metabolism, it was shown that OGT could inhibit neuronal apoptosis as a potential therapeutic target for brain I/R injury.

学科与关键词

关键词
ischemic stroke34-dihydroxybenzaldehydemetabolomicsmitochondrial dysfunctionuridine diphosphate N-acetylglucosamineO-GlcNAc transferase
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Molecular Medicine Reports
发表日期
2023-01
卷期
第 27 卷, 第 1 期
页码
9
DOI
10.3892/mmr.2022.12896
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Luo, Yuan (第一作者)

    yunnan univ

  • C

    Chen, Pu

    yunnan univ

查看全部 4 位作者收起作者
  • Y

    Yang, Liping

    yunnan univ

  • D

    Duan, Xiaohua (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417